Catalyst Wire Dossier Catalyst Wire Dossier

SGC001

· Beijing Sungen Biomedical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SGC001, covering 2025-11-25 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction [Phase 2]

See pricing